Pazopanib Clinical Trials
4 recruitingDrug
Phase 12Phase 22Phase 31Not Applicable1
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
AngiosarcomaLiposarcomaAdipocytic Neoplasm+6 more
St. Jude Children's Research Hospital139 enrolled6 locationsNCT06239272
Recruiting
Not Applicable
Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
Metastatic SarcomaResectable SarcomaRecurrent Sarcoma
M.D. Anderson Cancer Center20 enrolled1 locationNCT04199026
Recruiting
Phase 1Phase 2
Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Glioblastoma Multiforme
Centre Antoine Lacassagne51 enrolled1 locationNCT02331498
Recruiting
Phase 3
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
Renal Cell Carcinoma
Xynomic Pharmaceuticals, Inc.413 enrolled38 locationsNCT03592472